Medtronic received information regarding a guidance system being used during a spinal procedure.It was reported that a single level mis tlif at l4-l5 procedure was planned.After the right l5 guidewire was inserted, the surgeon realized there was something wrong when inserting the right l4 guidewire.Imaging was done with the c-arm and the surgeon found they were not in the planned trajectories.The screws intended for l5 were at l4 and the surgical arm was sent to the wrong level.Troubleshooting involved checking the plan and labeling and resending the surgical arm to the trajectory.The surgeon decided to abort the use of the guidance system and complete the procedure freehand using the c-arm.The patient's l3 exiting nerve root was damaged, but the patient's motor function was not impacted.The patient was still under observation.The procedure was delayed two hours.
|
H3: analysis of the exports and logs was completed.The complaint was investigated based on the provided description and export and logs review.According to clinical team, there was a misuse of the system, where the user disregarded many warnings and managed to mislead the software to upload irrelevant scan with a wrong arm location.According to software quality team, following export and logs review, it was concluded that the issue was associated to a known software defect, where the user can continue to operation in the first segment although the mount was opened in the second segment.The user can open the mount in the second segment, make mechanical shoulder shift, and continue to the operation of the first segment with the same scanning without new registration.Clinical analysis found that the reason the surgical arm was sent to the wrong level was misuse of the system.After scanning the patient with the o-arm, mount was unlocked and re-locked, leading to a change in arm location compared to scan.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|